| Jubilant Pharmova Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530019 |
NSE Symbol : JUBLPHARMA |
P/E(TTM) : 207.40 |
|
ISIN Demat : INE700A01033 |
Div & Yield% : 0.54 |
EPS(TTM) : 4.45 |
|
Book Value(₹) : 145.16 |
Market Cap(₹Cr) : 14,702.59 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 70.30 | 67.30 | 66.30 | 59.50 | 60.50 | 56.10 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 70.30 | 67.30 | 66.30 | 59.50 | 60.50 | 56.10 |
| Other Operating Income | 0.00 | 0.00 | 0.10 | 0.00 | 0.20 | 0.00 |
| Other Income | 0.50 | 0.40 | 42.40 | 2.40 | 13.00 | 2.80 |
| Total Income | 70.80 | 67.70 | 108.80 | 61.90 | 73.70 | 58.90 |
| Total Expenditure | 64.50 | 55.10 | 54.60 | 49.20 | 49.80 | 46.10 |
| PBIDT | 6.30 | 12.60 | 54.20 | 12.70 | 23.90 | 12.80 |
| Interest | 0.90 | 0.90 | 2.50 | 3.00 | 3.10 | 3.30 |
| PBDT | 5.40 | 11.70 | 51.70 | 9.70 | 20.80 | 9.50 |
| Depreciation | 1.30 | 1.60 | 1.60 | 1.50 | 1.50 | 1.50 |
| Tax | 0.20 | 1.80 | 1.40 | 1.20 | 5.00 | 6.30 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -53.30 | 1.70 | 55.10 | 1.20 | 0.70 | -3.60 |
| Reported Profit After Tax | 57.20 | 6.60 | -6.40 | 5.80 | 13.60 | 5.30 |
| Extra-ordinary Items | -8.50 | 0.00 | 41.60 | 1.70 | 12.70 | 2.70 |
| Adjusted Profit After Extra-ordinary item | 65.70 | 6.60 | -48.00 | 4.10 | 0.90 | 2.60 |
| EPS (Unit Curr.) | 3.59 | 0.42 | -0.40 | 0.36 | 0.86 | 0.33 |
| EPS (Adj) (Unit Curr.) | 3.59 | 0.42 | -0.40 | 0.36 | 0.86 | 0.33 |
| Calculated EPS (Unit Curr.) | 3.60 | 0.42 | -0.40 | 0.36 | 0.86 | 0.33 |
| Calculated EPS (Adj) (Unit Curr.) | 3.60 | 0.42 | -0.40 | 0.36 | 0.86 | 0.33 |
| Calculated EPS (Ann.) (Unit Curr.) | 14.39 | 1.66 | -1.61 | 1.46 | 3.42 | 1.33 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 14.39 | 1.66 | -1.61 | 1.46 | 3.42 | 1.33 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.90 | 15.90 | 15.90 | 15.90 | 15.90 | 15.90 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.96 | 18.72 | 81.75 | 21.34 | 39.50 | 22.82 |
| PBDTM(%) | 7.68 | 17.38 | 77.98 | 16.30 | 34.38 | 16.93 |
| PATM(%) | 81.37 | 9.81 | -9.65 | 9.75 | 22.48 | 9.45 |
